The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimers disease in adults 55 and older with memory or thinking changes. A negative result strongly ...

As of June 30, 2025, Neuphoria’s cash and cash equivalents were $14.2 million. The Company expects its current cash position to be sufficient to fund operations through the second fiscal quarter of ...

Scientists think those cholesterol-lowering statins might be doing something else we didn't know about: protecting our brains ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer’s patients, offering hope for slowing ...

Support the fight against Alzheimer’s at the St. George Walk to End Alzheimer’s, Saturday, Oct. 25 at Red Cliffs Mall. Funds ...

If replicated in humans, such an effect would slow or even reverse the progress of diseases like Alzheimer's, Huntington's, ...

Proposition 14 could set aside $3 billion for dementia research, transforming Texas's medical landscape and beyond.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Speaking ahead of the release of his new podcast show, the health expert shared the benefits of the supplement ...

Racing to End Alzheimer’s, driver Tom Long, and Hendricks Motorsports are set to join forces this weekend, with Long carrying ...